Biomirex Inc. is a unique antibody company that focuses on discovery of therapeutic antibodies against membrane proteins that represent over 50% of targets amenable for drug design. Since these protein targets require the presence of lipid bilayer for their structural and functional integrity, expression of properly folded and fully functional molecules becomes a very difficult task. The following areas of expertise make Biomirex a well positioned member of the antibody discovery group of companies:

• Antigen expression approaches that include gene codon optimization for high level of expression
• Range of antigen presentation platforms that provide fully functional target protein at high concentrations
• Established, optimized and highly customizable selection protocols
• High throughput screening technologies that provide identification of highly specific and often conformation-specific antibodies
• Antibody characterization assays including binding, ligand competition and various functional assays
• Licensed technology for high-level production of IgG for pre-clinical animal studies

Together with our partner organization Antherix, Biomirex owns unique FAB and ScFv Phage display libraries with complexities ranging from 10e10-10e11.